Simran Gupta Profile
Simran Gupta

@SimranGMD

Followers
415
Following
658
Media
18
Statuses
163

Transplant/Oncology ID fellow @bwh_ID @mghbwhIDfellows @harvardmed. former @MayoAZ_IMRES. @UConnHealth alum. Dog mom & dancer. Tweets my own

Boston, MA
Joined November 2021
Don't wanna be here? Send us removal request.
@SimranGMD
Simran Gupta
3 years
Honored and thrilled to have matched to the MGH/BWH ID fellowship!
@mgh_id
MGH Division of Infectious Diseases
3 years
Congratulations to our incoming MGH/BWH ID Fellowship Class! We are beyond thrilled to have you join us! #MatchDay
14
1
98
@CIDJournal
Clinical Infectious Diseases
3 months
Revising Sepsis Definitions to Better Target and Tailor Sepsis Care 🔗 https://t.co/Dp18TK9Y1J
0
9
21
@IDSAInfo
IDSA
3 months
In @CIDJournal, @JessicaLittleMD and colleagues evaluate the immunologic, virologic, and clinical outcomes of dual/extended antiviral therapy in severely immunocompromised patients with protracted SARS-CoV-2 infection.
Tweet card summary image
academic.oup.com
Outcomes of protracted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in immunocompromised hosts are poor despite standard antivir
0
4
13
@sanfordguide
Sanford Guide
4 months
ID Update July Edition is out. Get it free inside the #SanfordGuideAntimicrobial app.
0
14
38
@AliSMV7
Alí Sebastian Meza
4 months
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic Histoplasma Pulmonary Nodules https://t.co/hnC1Khu9Qh
0
61
167
@SimranGMD
Simran Gupta
4 months
Checkout our viewpoint! TLDR; PCT guided strategies in sepsis should focus on antibiotic discontinuation, but its real benefit may be in early application in the ED to support diagnostic reasoning, triage, and stewardship.
@CIDJournal
Clinical Infectious Diseases
4 months
Reassessing Procalcitonin-Guided Antibiotic Therapy in Critically Ill Patients with Sepsis: Lessons from the ADAPT-Sepsis Trial ✅ Just Accepted 🔗 https://t.co/GcJpZfAoZZ
1
3
14
@KottonNelson
Camille Nelson Kotton
4 months
Excited to have the 4th international CMV consensus guidelines officially published!!
@TransplantJrnl
Transplantation
4 months
July 2025 issue of @TransplantJrnl ! This issue highlights: ◼Consensus Guidelines on CMV Management ◼Organ Transplantation in the UAE ◼Sequential NRP and Normothermic Perfusion in Liver Transplantation ◼Predicting Long-Term Over-immunosuppression https://t.co/55buCjUaS4
0
15
44
@SimranGMD
Simran Gupta
5 months
Amazing review by Drs. Portales and Barshak!!
@Carlosportal3s
Carlos Portales
5 months
Out now! Our review on Jaw Osteomyelitis 💀🦠 An honor to have paired with expert in the field of head/neck infections and outstanding mentor Dr. Miriam Barshak for this one! https://t.co/aTehGiRK6U
0
2
8
@BogochIsaac
Isaac Bogoch
7 months
Ontario is reporting 557 cases of measles so far in 2025. We had 64 cases for all of 2024.
410
517
1K
@SimranGMD
Simran Gupta
10 months
Excited to share our research on Cocci antifungal ppx in SOT! TLDR; For patients repeatedly pos for EIA-IgM-only w no seroconversion, compatible clinical illness, or rads findings, discontinuing antifungal ppx may be reasonable after 1st posttxp yr https://t.co/T1Yqs9SklQ
journals.lww.com
by enzyme immunoassay (EIA-IgM-only), although this result may be falsely positive. Methods. We conducted a retrospective study at a large-volume transplant center in an endemic coccidioidomycosis...
0
3
5
@CalderwoodMD
Michael Calderwood, MD, MPH
1 year
Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia - Challenges the dogma. #IDWeek2024
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
These data suggest that among ICU or immunocompromised patients, severity of illness rather than initial antifungal choice drove clinical outcomes.
4
17
78
@SimranGMD
Simran Gupta
1 year
Just some #TxID fellows at #IDWeek2024 @MGHBWHIDFellows @mgh_id
3
4
32
@SimranGMD
Simran Gupta
1 year
Some fantastic NTM in immunocompromised hosts learning this morning. Challenging cases! #IDWeek2024
0
3
10
@SimranGMD
Simran Gupta
1 year
The actual best part of fellowship is the crew
@GaboMotoa
Gabriel Motoa, MD
1 year
One of the best things about coming to #IDWeek24 is to enjoy quality time with your fave people! @mgh_id @bwh_id @IDWeekmtg @MGHBWHIDFellows
0
0
20
@SimranGMD
Simran Gupta
1 year
One of the best parts of #IDWeek2024 is seeing my day 1 mentor !! @cocciqueen @MayoClinicINFD
0
1
19
@SimranGMD
Simran Gupta
1 year
Day 2 of #IDWeek2024 with unforgettable tropical medicine/global health cases! 🤯
0
2
11
@SimranGMD
Simran Gupta
1 year
Research 🤯
@NC_Renic
Neil Renic
1 year
Writing Editing
0
0
5
@SimranGMD
Simran Gupta
1 year
🙌
0
0
0
@BogochIsaac
Isaac Bogoch
1 year
Oropouche virus, which causes a dengue-like illness, is spreading across regions of Latin America & the Caribbean. Our study identifies the likely locations where travelers may present with this infection upon returning from these areas. https://t.co/xFvvABpfrf in @jtravmed.
2
48
114
@SimranGMD
Simran Gupta
1 year
Chief fellow !! Proud of @jaclyn_tuck 🙈
@JamieBeringMD
Jamie Bering, MD
1 year
Congratulations to our ⭐️⭐️⭐️ chief fellow @jaclyn_tuck for organizing such a successful @AmerGastroAssn SW Regional Women in GI conference!! #womeningi #empoweredwomen
0
0
2
@SimranGMD
Simran Gupta
1 year
This checks out
@MCPhillipsMD
McPhillips MD
1 year
0
0
8